Related Experiment Videos
Chromomycin A3 binds to left-handed poly(dG-m5dC).
R H Shafer1, B P Roques, J B LePecq
1Unité de Physicochimie Macromoleculaire, Institut Gustave Roussy, Villejuif.
European Journal of Biochemistry
|April 15, 1988
Summary
Chromomycin A3, an antitumor drug, binds to both right-handed B-DNA and left-handed Z-DNA. This interaction preserves the Z-DNA conformation, even at high drug concentrations.
Area of Science:
- Molecular Biology
- Biochemistry
- Drug Interactions
Background:
- Chromomycin A3 is an antitumor antibiotic.
- DNA exists in various conformations, including right-handed B-DNA and left-handed Z-DNA.
- Understanding drug-DNA interactions is crucial for developing new therapies.
Purpose of the Study:
- To investigate the interaction of chromomycin A3 with both B-DNA and Z-DNA.
- To determine if chromomycin A3 binding affects DNA conformation.
- To explore the binding characteristics of chromomycin A3 to different DNA forms.
Main Methods:
- Spectroscopic techniques including absorbance, fluorescence, and circular dichroism (CD).
- Nuclear Magnetic Resonance (NMR) spectroscopy (31P-NMR and 1H-NMR).
- Studies were conducted using synthetic polynucleotides poly(dG-dC) (B-form) and poly(dG-m5dC) (Z-form).
Main Results:
- Chromomycin A3 binding caused a red shift in absorbance and enhanced fluorescence for both DNA forms.
- CD spectra revealed distinct ellipticity signals for chromomycin A3 complexes with B-DNA (positive) and Z-DNA (negative).
- 31P-NMR confirmed that chromomycin A3 binding retains the Z-DNA conformation up to a 1:4 drug-to-base pair ratio and does not alter the B-Z DNA equilibrium.
Conclusions:
- Chromomycin A3 interacts with both B-DNA and Z-DNA, altering their spectroscopic properties.
- The drug preferentially binds to Z-DNA while maintaining its left-handed helical structure.
- Chromomycin A3's ability to bind Z-DNA without disrupting its conformation has implications for its antitumor activity.